Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 5, Iss. 3, pp. 872-888
Open Access | Times Cited: 387

Showing 1-25 of 387 citing articles:

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost, et al.
JAMA (2021) Vol. 325, Iss. 16, pp. 1620-1620
Open Access | Times Cited: 591
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado, et al.
The Lancet (2021) Vol. 397, Iss. 10291, pp. 2253-2263
Open Access | Times Cited: 448
Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
COVID-19: breaking down a global health crisis
Saad I. Mallah, Omar Ghorab, Sabrina Al-Salmi, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 305
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Jenneke Leentjens, Thijs F. van Haaps, Pieter Wessels, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 7, pp. e524-e533
Open Access | Times Cited: 218
Therapeutic advances in COVID-19
Naoka Murakami, Robert Hayden, Thomas Hills, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 38-52
Open Access | Times Cited: 128
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: A multi‐center, open‐label, randomized controlled trial
Usha Perepu, Isaac Chambers, Abdul Wahab, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 9, pp. 2225-2234
Open Access | Times Cited: 120
COVID-19, Myocarditis and Pericarditis
DeLisa Fairweather, Danielle J. Beetler, Damian N. Di Florio, et al.
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1302-1319
Open Access | Times Cited: 112
Thromboprophylaxis in Patients With COVID-19
Lisa K. Moores, Tobias Tritschler, Shari B. Brosnahan, et al.
CHEST Journal (2022) Vol. 162, Iss. 1, pp. 213-225
Open Access | Times Cited: 79
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
Gregg W. Stone, Michael E. Farkouh, Anuradha Lala, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1747-1762
Open Access | Times Cited: 48
Pharmacology of Heparin and Related Drugs: An Update
John Hogwood, Barbara Mulloy, R. Lever, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 2, pp. 328-379
Open Access | Times Cited: 47
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Chronic Lung Injury after COVID-19 Pneumonia: Clinical, Radiologic, and Histopathologic Perspectives
Min Jae, Joshua J. Solomon, Jong Eun Lee, et al.
Radiology (2024) Vol. 310, Iss. 1
Closed Access | Times Cited: 14
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XII – Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMA
Antonio Bognanni, Alessandro Fiocchi, Stefania Arasi, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 4, pp. 100888-100888
Open Access | Times Cited: 14
COVID-19 and Sepsis
Zeliha Koçak Tufan, Bircan Kayaaslan, Mervyn Mer
TURKISH JOURNAL OF MEDICAL SCIENCES (2021) Vol. 51, Iss. SI-1, pp. 3301-3311
Open Access | Times Cited: 73
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 01, pp. 131-141
Open Access | Times Cited: 68
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega‐Paz, Mattía Galli, Davide Capodanno, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2021) Vol. 8, Iss. 7, pp. 677-686
Open Access | Times Cited: 65
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 6, Iss. 2, pp. 664-671
Open Access | Times Cited: 64
Disseminated intravascular coagulation and its immune mechanisms
Narcis I. Popescu, Cristina Lupu, Florea Lupu
Blood (2021) Vol. 139, Iss. 13, pp. 1973-1986
Open Access | Times Cited: 62
The ecosystem of health decision making: from fragmentation to synergy
Holger J. Schünemann, Marge Reinap, Thomas Piggott, et al.
The Lancet Public Health (2022) Vol. 7, Iss. 4, pp. e378-e390
Open Access | Times Cited: 61
A Framework for the Development of Living Practice Guidelines in Health Care
Ibrahim K El Mikati, Joanne Khabsa, Tarek Harb, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 8, pp. 1154-1160
Closed Access | Times Cited: 61
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 5, Iss. 20, pp. 3951-3959
Open Access | Times Cited: 58
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2022) Vol. 6, Iss. 17, pp. 4915-4923
Open Access | Times Cited: 56
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Edward R. Kastenhuber, Marisa Mercadante, Benjamin E. Nilsson-Payant, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 55
Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target
Pasquale Ambrosino, Ilenia Calcaterra, Marco Mosella, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 812-812
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top